Co-Authors
This is a "connection" page, showing publications co-authored by Manli Wang and Hengrui Hu.
Connection Strength
0.957
-
Infection of human sweat glands by SARS-CoV-2. Cell Discov. 2020 Nov 13; 6(1):84.
Score: 0.228
-
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020; 6:28.
Score: 0.220
-
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020; 6:16.
Score: 0.218
-
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries. Cell Discov. 2021 Jul 27; 7(1):57.
Score: 0.060
-
Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct Target Ther. 2021 05 17; 6(1):195.
Score: 0.059
-
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes. PLoS Biol. 2021 05; 19(5):e3001209.
Score: 0.059
-
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
Score: 0.056
-
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infect Dis. 2020 09 11; 6(9):2524-2531.
Score: 0.056